This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Thomas Hense: Innovator in Chromane Compounds
Introduction
Thomas Hense is a notable inventor based in Recklinghausen, Germany. He has made significant contributions to the field of chemistry, particularly in the production of chromane compounds. His work focuses on developing methods that can lead to advancements in medical applications, specifically in the area of platelet aggregation inhibitors.
Latest Patents
Hense holds a patent for "Methods for producing amino substituted chromanes and intermediates thereof." This patent discloses processes for producing chromane compounds, including chroman-2-yl acetic acid compounds and 6-amino-chroman-2-yl acetic acid esters. These compounds serve as intermediates for creating platelet aggregation inhibitors and are themselves potent inhibitors.
Career Highlights
Throughout his career, Thomas Hense has been associated with Millennium Pharmaceuticals Limited. His innovative work has led to the development of important chemical processes that have potential applications in pharmaceuticals. Hense's expertise in this area has positioned him as a valuable contributor to the field.
Collaborations
Hense has collaborated with notable colleagues, including James P Kanter and John J G Mullins. These partnerships have likely enhanced the scope and impact of his research, fostering an environment of innovation and discovery.
Conclusion
In summary, Thomas Hense is a distinguished inventor whose work in chromane compounds has the potential to influence the development of new medical therapies. His contributions to the field are marked by his patent and collaborations with other experts.
